NCT02871258

MetaNeb® Chest X-ray Study

Evaluation of The MetaNeb® System to Reduce Atelectasis Assessed by Chest X-ray

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 8 (actual)
• Sponsor: Hill-Rom · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To study objective is to evaluate the impact of use of The MetaNeb® System in clearance of atelectasis, as demonstrated by improvement in chest x-rays. This is a a non-randomized open label study, with all subjects receiving treatment with The MetaNeb® System. Subjects who qualify for enrollment in the study will receive therapy with The MetaNeb® System following the labeled instructions for the device. Details of the treatment including duration and frequency will be defined in treatment procedures.

Detailed description

Study Population: Post-surgical (thoracic, cardiac or abdominal surgery) non-mechanically ventilated patients with significant atelectasis as documented by chest x-ray results. Duration of treatment: Duration of treatment with The MetaNeb® System will be a minimum of 48 hours, or until the subject is discharged from the hospital (if discharge is earlier). Enrolled subjects will remain in the study through Day 4 or until the subject is discharged from the hospital, whichever occurs sooner.

Conditions

• Atelectasis

Interventions

Type	Name	Description
DEVICE	The MetaNeb® System

Timeline

• Start date: 2016-09-01
• Primary completion: 2017-08-17
• Completion: 2017-08-17
• First posted: 2016-08-18
• Last updated: 2024-09-24
• Results posted: 2024-09-24

Locations

1 site across 1 country: United States